Dr Ing is trading at 53.82 as of the 17th of March 2025. This is a 1.07 percent decrease since the beginning of the trading day. The stock's lowest day price was 53.4. Dr Ing has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Dr Ing's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Dr Ing or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Although Dr Ing's alpha and beta are two of the key measurements used to evaluate Dr Ing's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Dr Ing without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Equity Forecasting Now
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Elected by the shareholders, the Dr Ing's board of directors comprises two types of representatives: Dr Ing inside directors who are chosen from within the company, and outside directors, selected externally and held independent of P911. The board's role is to monitor Dr Ing's management team and ensure that shareholders' interests are well served. Dr Ing's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Ing's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dr Ing financial ratios help investors to determine whether P911 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in P911 with respect to the benefits of owning Dr Ing security.